type here...

CATEGORIES

Diabetes

LATEST

1...345...13Page 4 of 13

TRENDING

EDITORS CHOICE

SNAP at Risk: What a Shutdown Means for Health and America’s Social Contract

Gil Bashe, Medika Life Editor -
When Federal systems stall, people’s lives don’t pause. The government shutdown has threatened the Supplemental Nutrition Assistance Program (SNAP), the nation’s largest anti-hunger initiative...

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

Medika Life -
Renowned Endocrinologist Leon Igel MD, Recognized for Pioneering Work in Diabetes and Obesity Management

GLP‑1 Medications in Later Life: Why the “Miracle Shot” Needs a Senior‑Specific Safety Lens

Pat Farrell PhD -
When GLP-1 medications like semaglutide began to gain attention, many people saw them as a breakthrough. For some people, these drugs help lower blood sugar,...

Galen Growth FemTech 2.0 Report: Elevating Women’s Health from Niche to Necessity

Gil Bashe, Medika Life Editor -
There’s a truth in health innovation: “Where data meets intent, change follows.” The latest Galen Growth report—FemTech 2.0: Doubling Down on Growth—is not just...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories